Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases – Eli Lilly

Written by

admin

in

  1. Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases  Eli Lilly
  2. Pharmalittle: We’re reading about an Eli Lilly deal, an Amgen acquisition, and much more  statnews.com
  3. After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis  Investing.com
  4. Ventyx’s $1.2B buyout by Eli Lilly proves timing often beats conviction in biotech investing — a VC explains  MSN
  5. Eli Lilly to acquire Ventyx Biosciences in $1.2B deal  Axios

Continue Reading

More posts